Yang Ke
180 Fenglin Road
Zhongshan, China
Zhongshan, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
The efficacy, safety, and rationale of orelabrutinib combined with obinutuzumab (O2) as a first-line systemic treatment for marginal zone lymphoma.
Journal: Blood cancer journal
Published: March 22, 2026
Polatuzumab Vedotin, zanubrutinib and rituximab (Pola-ZR) achieved rapid and deep response in untreated frail and elderly DLBCL.
Journal: Annals of hematology
Published: August 18, 2024
A prognostic model incorporating inflammatory cells and cytokines for newly diagnosed multiple myeloma patients.
Journal: Clinical and experimental medicine
Published: October 23, 2022
TCR CDR3 Sequencing as a Clue to Elucidate the Landscape of Dysimmunity in Patients with Primary Immune Thrombocytopenia.
Journal: Journal of clinical medicine
Published: August 01, 2022
Interleukin (IL)-1 family cytokines could differentiate primary immune thrombocytopenia from systemic lupus erythematosus-associated thrombocytopenia.
Journal: Annals of translational medicine
Published: March 12, 2021
Cytokine Consistency Between Bone Marrow and Peripheral Blood in Patients With Philadelphia-Negative Myeloproliferative Neoplasms.
Journal: Frontiers in medicine
Published: August 24, 2020
Intestinal microbiota dysbiosis play a role in pathogenesis of patients with primary immune thrombocytopenia.
Journal: Thrombosis research
Published: February 13, 2020
Role of prophylactic radiotherapy in Chinese patients with primary testicular diffuse large B-cell lymphoma: a single retrospective study.
Journal: Journal of B.U.ON. : official journal of the Balkan Union of Oncology
Published: May 26, 2019
Transcription Factor IRF4 Dysfunction Affects the Immunosuppressive Function of Treg Cells in Patients with Primary Immune Thrombocytopenia.
Journal: BioMed research international
Published: March 01, 2019
The prediction value of Treg cell subtype alterations for glucocorticoid treatment in newly diagnosed primary immune thrombocytopenia patients.
Journal: Thrombosis research
Published: February 18, 2019
Last Updated: 09/26/2026